What is the ROE (Return on Equity) of Spirox this year?
The ROE of Spirox this year is -0.02 undefined.
Spirox ROE 2024
Spirox ROE
-0.02
Ticker
3055.TW
ISIN
TW0003055000
In 2024, Spirox's return on equity (ROE) was -0.02, a -125.79% increase from the 0.09 ROE in the previous year.
Spirox Aktienanalyse
What does Spirox do?
The Spirox Corporation is a company that was founded in 2007 and is headquartered in Menlo Park, California. The company operates in the medical technology industry and specializes in the development of products for nasal breathing. The mission of Spirox is to help people who have difficulty breathing through their nose. The company has recognized that many people have difficulty breathing through their nose due to congestion or other issues. Breathing through the mouth, however, can lead to a range of health problems such as dry mouth, sleep apnea, and respiratory infections. Therefore, Spirox has set out to develop innovative solutions to facilitate nasal breathing. Spirox's products include both implantable and non-implantable solutions. The company has a small but effective product portfolio consisting of two products: the Latera Nasal Stent and the AeroForm Nasal Stent. The Latera Nasal Stent is used to permanently open the nasal passages and facilitate breathing. The placement of the stent is a minimally invasive procedure that is typically performed on an outpatient basis. The Latera Nasal Stent is inserted and secured in the nasal wings to allow for better airflow through the nostrils. The stent is made of polydioxanone (PDO), a biocompatible polymer fiber that is absorbed by the body. Spirox's second product, the AeroForm Nasal Stent, is a non-implantable nasal stent used for temporary relief of nasal breathing. The AeroForm is a soft stent made of a flexible polymer material. It is inserted into the nasal passages and forms a gentle expansion to facilitate nasal breathing. As a company, Spirox focuses on collaboration with specialists and clinics to ensure that their products have high success rates. The company has established a partnership with the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) to advance scientific research and development in the nasal breathing industry. Spirox is led by experienced executives from the medical technology industry. The CEO, Duke Rohlen, has over 20 years of experience in leading medical technology companies such as Inspire Medical Systems and CV Ingenuity. The board team also includes Elektra Papadopoulos as Chair of the Board, who has worked at Hologic and Boston Scientific, among others. Although Spirox is a relatively small company, it has already received several awards. In 2017, the company was awarded the Red Herring Top 100 North America Award, which recognizes companies that are leading in the innovation industry. Overall, Spirox is an emerging company in the medical technology industry that offers innovative solutions to facilitate nasal breathing. Through collaboration with doctors and clinics and a focus on scientific research, the company aims to improve the success and effectiveness of its products. Spirox ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Spirox's Return on Equity (ROE)
Spirox's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Spirox's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Spirox's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Spirox’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Spirox stock
How has the Return on Equity (ROE) of Spirox developed compared to the previous year?
The ROE of Spirox has increased by -125.79% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Spirox?
A high ROE indicates that Spirox generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Spirox?
A low ROE can indicate that Spirox is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Spirox affect the company?
A change in ROE (Return on Equity) of Spirox can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Spirox?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Spirox?
Some factors that can influence Spirox's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Spirox pay?
Over the past 12 months, Spirox paid a dividend of 1 TWD . This corresponds to a dividend yield of about 1.48 %. For the coming 12 months, Spirox is expected to pay a dividend of 0.87 TWD.
What is the dividend yield of Spirox?
The current dividend yield of Spirox is 1.48 %.
When does Spirox pay dividends?
Spirox pays a quarterly dividend. This is distributed in the months of October, August, August, August.
How secure is the dividend of Spirox?
Spirox paid dividends every year for the past 0 years.
What is the dividend of Spirox?
For the upcoming 12 months, dividends amounting to 0.87 TWD are expected. This corresponds to a dividend yield of 1.29 %.
In which sector is Spirox located?
Spirox is assigned to the 'Information technology' sector.
Wann musste ich die Aktien von Spirox kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Spirox from 8/6/2024 amounting to 1.011 TWD, you needed to have the stock in your portfolio before the ex-date on 7/5/2024.
When did Spirox pay the last dividend?
The last dividend was paid out on 8/6/2024.
What was the dividend of Spirox in the year 2023?
In the year 2023, Spirox distributed 0.2 TWD as dividends.
In which currency does Spirox pay out the dividend?
The dividends of Spirox are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Spirox
Our stock analysis for Spirox Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spirox Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.